ARWR’s latest rating updates from top analysts.

CHWY Stock

Arrowhead Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Hamilton James C unloaded Company’s shares for reported $0.19 million on Aug 15 ’25. In the deal valued at $20.00 per share,9,389 shares were sold. As a result of this transaction, Hamilton James C now holds 262,122 shares worth roughly $5.55 million.

Then, Hamilton James C sold 611 shares, generating $12,220 in total proceeds. Upon selling the shares at $20.00, the Chief Medical Officer now owns 271,511 shares.

Before that, Hamilton James C bought 9,389 shares. Arrowhead Pharmaceuticals Inc shares valued at $187,750 were divested by the Officer at a price of $20.00 per share.

Goldman initiated its Arrowhead Pharmaceuticals Inc [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.

Price Performance Review of ARWR

On Tuesday, Arrowhead Pharmaceuticals Inc [NASDAQ:ARWR] saw its stock jump 2.27% to $21.18. Over the last five days, the stock has gained 6.65%. Arrowhead Pharmaceuticals Inc shares have fallen nearly -13.09% since the year began. Nevertheless, the stocks have risen 12.66% over the past one year. While a 52-week high of $27.34 was reached on 02/07/25, a 52-week low of $9.57 was recorded on 04/07/25.

Levels Of Support And Resistance For ARWR Stock

The 24-hour chart illustrates a support level at 20.77, which if violated will result in even more drops to 20.36. On the upside, there is a resistance level at 21.41. A further resistance level may holdings at 21.64.

How much short interest is there in Arrowhead Pharmaceuticals Inc?

A steep rise in short interest was recorded in Arrowhead Pharmaceuticals Inc stocks on 2025-08-15, growing by 0.57 million shares to a total of 12.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 12.42 million shares. There was a rise of 4.36%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.